scPharmaceuticals Inc. (NASDAQ: SCPH) Stock Information | RedChip

scPharmaceuticals Inc. (NASDAQ: SCPH) Listen to this Section


$5.19
+0.1300 ( +2.57% ) 365.4K

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Market Data


Open


$5.19

Previous close


$5.06

Volume


365.4K

Market cap


$187.12M

Day range


$5.06 - $5.29

52 week range


$3.24 - $8.05

Insider Ownership Transactions

Total Amount Purchased: -161,369.00 | $ -837,505.11

Date Type Amount Purchased Purchaser
2024-01-22 Sale -41840.00 Nokes Rachael
2024-01-22 Sale -113560.00 Tucker John H
2024-01-03 Sale -1027.00 Nokes Rachael
2024-01-03 Sale -4942.00 Tucker John H

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
8-k 8K-related 13 May 16, 2024
10-q Quarterly Reports 69 May 14, 2024
8-k 8K-related 14 May 14, 2024
def Proxies and info statements 9 Apr 26, 2024
pre Proxies and info statements 8 Apr 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.